Do you want to read an article? Please log in or register.
Immunotherapy for brain tumors: understanding early successes and limitations
Immunotherapy
Related content
Immunotherapy
Tumor Mutational Burden as a Pan-cancer Biomarker for Immunotherapy: The Limits and Potential for Convergence
Cancer Cell
Passaro A, Stenzinger A, Peters S
doi: 10.1016/j.ccell.2020.10.019
Immunotherapy
Epigenetic mechanisms of tumor resistance to immunotherapy
Cell Mol Life Sci.
Arenas-Ramirez N, Sahin D, Boyman O
doi: 10.1007/s00018-
ImmunotherapyImmunomodulation
Tumor-associated carbohydrates and immunomodulatory lectins as targets for cancer immunotherapy
★ 3
Recommended by
Alexander Meisel, Faculty Member
J Immunother Cancer
Rodrigues Mantuano N, Natoli M, Zippelius A, Läubli H
doi: 10.1136/jitc-2020-001222
Melanoma and Skin Cancer
PD-1 inhibitors might limit the development of brain metastases in patients with advanced melanoma
Melanoma Res
Marcaillou M, Linder C, Chaltiel L, Sibaud V, Pagès C, Modesto A, Chira C, Dalmasso C, Boulinguez S, Bedane C, Meyer N
doi: 10.1097/CMR.0000000000000700
Immunotherapy
Is autoimmunity the Achilles' heel of cancer immunotherapy?
Nat Med.
June CH, Warshauer JT, Bluestone JA
doi: 10.1038/nm.4321.
Immunotherapy
Examining Peripheral and Tumor Cellular Immunome in Patients With Cancer
Front Immunol.
Holl EK, Frazier VN, Landa K, Beasley GM, Hwang ES, Nair SK
doi: 10.3389/fimmu.2019.01767.
Immunotherapy
Immunotherapy and radiation therapy for malignant pleural mesothelioma
Transl Lung Cancer Res.
Alley EW, Katz SI, Cengel KA, Simone CB
doi: 10.21037/tlcr.2017.04.01.
Allergic DiseasesImmunotherapy
Early decrease in basophil sensitivity to Ara h 2 precedes sustained unresponsiveness after peanut oral immunotherapy
J Allergy Clin Immunol.
Patil SU, Steinbrecher J, Calatroni A, Smith N, Ma A, Ruiter B, Virkud Y, Schneider M, Shreffler WG
doi: 10.1016/j.jaci.2019.07.028.
T Cells
Cancer immunotherapy with check point inhibitor can cause autoimmune adverse events due to loss of Treg homeostasis
Semin Cancer Biol.
Kumar P, Saini S, Prabhakar BS
doi: 10.1016/j.semcancer.